In todays competitive and high-stakes pharmaceutical market, companies seek any advantage to expedite their products’ arrival. They have adopted lean practices, intensified quality initiatives to monitor processes in real-time and catch deviations early, eliminated redundancy, reduced waste, and, where possible, transitioned to digital systems to minimize manual errors and increase the speed of data processing.
Pharma companies must develop robust risk management strategies to prepare for regulatory uncertainties. Understanding the industry’s current regulatory ambiguities and assessing those regulatory risks and requirements is a critical foundational step in any project. Your regulatory team needs to stay informed about a multitude of factors, including changes in legislation, guidelines, or enforcement actions practiced by regulatory bodies, as these are always changing. In addition, your team must proactively develop and adapt strategies to ensure compliance and mitigate risks.
What do you need to do to develop these risk management strategies? This post will cover the three critical stages of developing a strong risk management strategy and factors to consider for each stage.
Three Key Stages to Developing a Risk Management Strategy for Regulatory Issues
1) Understand Regulatory Requirements and Uncertainties
While this may seem obvious, it often does not receive the attention it deserves. Problems in R&D experiments or on the manufacturing line tend to take precedence, diverting crucial time away from preventing regulatory issues as people are pulled from risk management meetings to address the immediate crises. This causes the risk management plan to suffer from a lack of attention.
“But we have to put out the ‘fire’!” Of course you do, but without a strategic approach, such as a dedicated regulatory team, you risk facing a compliance fire that can seriously delay your product’s market entry. For example, incomplete or inaccurate documentation due to neglect can delay product approval or even result in rejection.
Part of a dedicated regulatory team’s mandate would be to set up processes to monitor and notify them of changing legislation or regulations, with a procedure to follow, such as determining who and what areas of work the changes affect and informing them accordingly. This could involve identifying whether the changes require new data-keeping requirements, updated documentation, or even a fundamental shift in a process. Whatever the necessary adjustments, this information also needs to be communicated up the chain of command and monitored to ensure compliance and timely implementation.
2) Assessing Regulatory Risks within the Organization
Assessing regulatory risks and requirements should be a priority at the inception of any new project. By evaluating these aspects across the product’s life cycle—from preclinical development to commercialization—you can significantly reduce the time and effort needed to address the issues identified after regulatory submission. Proper preparation early on correlates with fewer complications and corrections later.
Regulatory submission is a multidisciplinary endeavor requiring careful orchestration from inception to commercialization. A well-crafted filing strategy is essential for navigating regulatory waters smoothly. Each stage of the development process must have its own procedures to save time, resources, and prevent mistakes and the dreaded observations. While each area has its specific role, all must align with the overall strategic plan.
Specific factors to consider when doing a project risk assessment include:
Product complexity – In the excitement of discovering a potential new drug, particularly for a rare disease, it is easy for a company to overlook the later, complex phases of drug development when doing the initial risk assessment. It is essential to ask:
- Do we have the resources to take this drug all the way to commercialization?
- Are the necessary systems in place?
- Do we need further digital transformation to meet our proposed timeframe?
Regulatory history – Historical data can highlight common pitfalls that previously caused delays or rejections, helping you to tailor your submission to meet regulatory expectations.
- It can provide benchmarks for safety and efficacy standards.
- By knowing the length of time, it took similar drugs to move through the regulatory process, you can better estimate timelines and plan costs and resources accordingly.
Geographic markets – Different global regions will have their own regulatory challenges. Understanding these can help anticipate potential issues and prepare strategies to address them.
- Understanding past regulatory approvals and rejections is, once again, important. It helps identify the most efficient pathways to market entry in each respective region.
Overall competitive landscape – Knowing which drugs have been approved or rejected gives insight into the competitive landscape, helping to identify market opportunities.
3) Mitigating Regulatory Strategy Risks
The third key stage is that of mitigation. It requires companies to develop strategies tailored to remedy each pre-identified regulatory risk. Quality Management Systems (QMS) and compliance programs play a crucial role in ensuring adherence to regulatory requirements. Risks identified during the risk assessment must be remediated, with improvements standardized in existing processes and systems. You will need to:
- Establish and standardize communication channels within your organization, ensuring everyone is aware of the requirements.
- Treat regulatory agencies as thought partners and standardize lines of communication with them.
From Insight to Implementation: Proactive Solutions with LGM Pharma as Your Partner
Part of risk mitigation can involve collaborating with a team experienced and knowledgeable in regulatory requirements, whose job is to stay current with ever-changing regulations, saving you time and ensuring a smooth process.
LGM Pharma is a smart choice to partner with you to maintain compliance throughout the drug life cycle and assist you in receiving FDA approval. We have more than two decades of experience with submissions, filings, registrations, licensing, and labeling.
For more information, contact LGM Pharma.